News - Page 249 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Silo Pharma, Inc. (SILO) Announces Successful Uplisting To the OTCQB Venture Market

Silo Pharma, Inc. (SILO) Announces Successful Uplisting To the OTCQB Venture Market

Post published:October 14, 2020
Post category:Press Release

Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council

Post published:October 14, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

Post published:October 14, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. Enters into Option Agreement with University of Maryland Baltimore for Central Nervous System-Homing Peptides

Silo Pharma, Inc. Enters into Option Agreement with University of Maryland Baltimore for Central Nervous System-Homing Peptides

Post published:October 13, 2020
Post category:Press Release

PharmaDrug’s Super Smart Begins to Work with Essential Good to Develop Its Brand and Build an Innovative Online Retail Platform

Post published:October 13, 2020
Post category:Press Release

Read more about the article Mind Cure Announces Addition of Neuroscientist Dr. Wolfram Tetzlaff to Scientific Advisory Board

Mind Cure Announces Addition of Neuroscientist Dr. Wolfram Tetzlaff to Scientific Advisory Board

Post published:October 13, 2020
Post category:Press Release

Read more about the article Psychedelic Bulletin: Field Trip Lists on the CSE; MindMed Partners with NYU; Zuckerberg Supports Decriminalisation

Psychedelic Bulletin: Field Trip Lists on the CSE; MindMed Partners with NYU; Zuckerberg Supports Decriminalisation

Post published:October 9, 2020
Post category:Psychedelic Bulletin

Read more about the article MindMed Announces $25 Million Bought Deal Public Offering

MindMed Announces $25 Million Bought Deal Public Offering

Post published:October 9, 2020
Post category:Press Release

Read more about the article Health and Wellness Industry Tastemaker Jon Bier Joins Mind Cure’s Advisory Board

Health and Wellness Industry Tastemaker Jon Bier Joins Mind Cure’s Advisory Board

Post published:October 8, 2020
Post category:Press Release

Read more about the article Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board

Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board

Post published:October 8, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.